1. Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma 
Robert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, Xiabao Zhong, Jonathan Thompson, Timothy S. Fenske, Mary M. Horowitz, Richard Komorowski, Jeanne Palmer, Marcelo C. Pasquini, J. Douglas Rizzo, Wael Saber, Mathew Thomas, William R. Drobyski 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 9, Pages (September 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Transplantation outcomes in all patients with and without ES. Cumulative incidence of transplantation-related mortality (TRM) and relapse are depicted in panels A and B. Probability of progression-free survival and overall survival are shown in panels C and D.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Transplantation outcomes in multiple myeloma patients with and without ES. Cumulative incidence of transplantation-related mortality (TRM) and relapse are depicted in panels A and B. Probability of progression-free survival and overall survival are shown in panels C and D.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions